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BACKGROUND
Infectious haematopoietic necrosis is caused by a single stranded RNA virus of the family •	 Rhabdoviridae, genus 
Novirhabdoviridae. IHN is listed as a non-exotic disease under EU Directive 2006/88/EC, and is notifiable in Ireland, 
according to S.I. No. 261 of 2008. 
IHN was first reported in North America in the 1950’s and has since been reported in Japan and continental Europe.•	
Horizontal transmission of the virus is the main cause of disease spread through direct contact between fish or by •	
virus shedding from infected fish. 
IHN primarily affects all salmonid species in both marine and freshwater, with fry and fingerlings particularly •	
susceptible.
Ireland has been officially declared free of IHN, by Commission Decision 2009/177/EC •	
CLINICAL SIGNS
Infected fish are often lethargic, with occasional bouts of frenzied abnormal activity.•	
Externally, skin darkening, pale gills, extended abdomen, exophthalmia and petechial haemorrhages can be observed.•	
Internally, fish are anaemic, with a pale liver, spleen and kidney. •	
Haemorrhaging, oedema and impaired osmotic balance are often observed in the final stages of infection.•	
Clinical disease typically occurs between 8 and 15•	 oC and cumulative mortality in acute outbreaks may exceed 90% with 
protracted losses observed in chronic outbreaks.
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DIAGNOSIS
The ‘Gold Standard’ for detection of IHNV is virus isolation in cell culture followed by immunological and/or molecular •	
detection.
Histopathologically, the disease is characterised by degenerative necrosis of the haematopoetic tissues, kidney, •	
spleen, liver, pancreas and digestive tract. 
Molecular diagnostics have identified three genogroups of the IHN virus: U, M and L. European isolates all belong to •	
the M genogroup.
CONTROL
A DNA vaccine against IHN is currently approved for use in Canada.•	
Vaccination against IHN is not permitted in areas of the EU which have been declared disease free.•	
Control measures focus on prevention through disinfection of fertilised eggs, use of virus-free water supplies, •	
purchasing stock from disease-free sources and strict biosecurity measures.
A range of disinfectants are effective against the IHN virus e.g. sodium hydroxide, chlorine and iodine based •	
compounds.
WHAT SHOULD I DO?
The Marine Institute must be notified in the event of unexplained mortality or the suspicion of a notifiable disease. •	
Strict biosecurity measures should be implemented at and around the infected site, in collaboration with the Marine •	
Institute and the retained veterinary practitioner.
No movements of aquatic animals, whether dead or alive, are allowed without the authorisation of the official service.•	
The Marine Institute will confirm or rule out the presence of a listed disease.•	
If the presence of the disease is confirmed, aquaculture animals should be harvested/culled as soon as possible to •	
avoid the spread of the disease.
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